Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant electrochemotherapy for colorectal cancer – randomized controlled trial
2020-000835-33Phase 2Active
- Sponsor
- Zealand University Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bleomycin in colorectal cancer (CRC) (2 arms), sponsored by Zealand University Hospital. Primary endpoint: Tumor downstaging efficacy. Started Mar 2020; status: active.
02
Drugs
bleomycin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2020-000835-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000835-33.